To identify patient characteristics and comorbidities of patients treated with enzalutamide or abiraterone
Latest Information Update: 28 Jul 2021
At a glance
- Drugs Abiraterone (Primary) ; Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Jul 2021 New trial record
- 08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology